References
- Agarwal A , PritchardD , GullettL , AmantiKG , GustavsenG. A quantitative framework for measuring personalized medicine integration into US healthcare delivery organizations. J. Pers. Med.11(3), 196 (2021).
- National Human Genome Research Institute . International Consortium Completes Human Genome Project (2003). www.genome.gov/11006929/2003-release-international-consortium-completes-hgp
- Personalized Medicine Coalition . Personalized medicine at FDA the scope significance of progress in 2020 (2020). www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PM_at_FDA_The_Scope_Significance_of_Progress_in_2020.pdf
- U.S. Food and Drug Administration . Cellular gene therapy products (2020). www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products
- O’Day E , AlsafarH. Scientific American. Advanced Diagnostic for Personalized Medicine (2018). www.scientificamerican.com/article/advanced-diagnostics-for-personalized-medicine/
- Phillips KA , DeverkaPA , HookerGW , DouglasMP. Genetic test availability and spending: where are we now? Where are we going?Health Aff.37(5), 710–716 (2018).
- Maranville JC , DiRienzo A. Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases. Pharmacogenomics15(15), 1931–1940 (2014).
- Chen M , ZhaoH. Next-generation sequencing in liquid biopsy: cancer screening and early detection. Hum. Genomics13, 34 (2019).
- U.S. Food and Drug Administration . FDA approves liquid biopsy NGS companion diagnostic test for multiple cancers and biomarkers (2020). www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-liquid-biopsy-ngs-companion-diagnostic-test-multiple-cancers-and-biomarkers
- Hulsen T , JamuarSS , MoodyARet al. From big data to precision medicine. Front. Med.6, 34 (2019).
- Cohen J . Forbes. Using clinical decision support tools to facilitate decision-making in precision medicine (2019). www.forbes.com/sites/joshuacohen/2019/11/05/using-clinical-decision-support-tools-to-facilitate-decision-making-in-precision-medicine/?sh=404f6574f756
- Sutton RT , PincockD , BaumgartDCet al. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit. Med.3, 17 (2020).
- Mazieres J , DrilonA , LusqueAet al. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. Ann. Oncol.30(8), 1321–1328 (2019).
- Gutierrez ME , ChoiK , LanmanRBet al. Genomic profiling of advanced non-small-cell lung cancer in community settings: gaps and opportunities. Clin. Lung Cancer18(6), 651–659 (2017).
- Steuten L , GoulartB , MeropolNJ , PritchardD , RamseySD. Cost–effectiveness of multigene panel sequencing for patients with advanced non-small-cell lung cancer. JCO Clin. Cancer Inform.3, 1–10 (2019).
- Tsimberidou AM , ElkinS , DumanoisR , PritchardD. Clinical and economic value of genetic sequencing for personalized therapy in non-small-cell lung cancer. Clin. Lung Cancer21(6), 477–481 (2020).
- National Human Genome Research Institute . Implementing genomics in practice (IGNITE) (2016). www.genome.gov/27554264
- National Human Genome Research Institute . Electronic medical records and genomics (EMERGE) network (2016). www.genome.gov/27540473
- Rehm HL , BergJS , BrooksLDet al. ClinGen – the clinical genome resource. N. Engl. J. Med.372(23), 2235–2242 (2015).
- Roundtable on Translating Genomic-Based Research for Health ; Board on Health Sciences Policy; Institute of Medicine. Genomics-enabled learning health care systems: gathering and using genomic information to improve patient care and research: workshop summary. National Academies Press, DC, USA (2015). www.nap.edu/catalog/21707/genomics-enabled-learning-health-care-systems-gathering-and-using-genomic
- Caudle KE , GammalRS , Whirl-CarrilloM , HoffmanJM , RellingMV , KleinTE. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Am. J. Health Syst. Pharm.73(23), 1977–1985 (2016).
- Pritchard DE , MoeckelF , VillaMS , HousmanLT , McCartyCA , McLeodHL. Strategies for integrating personalized medicine into healthcare practice. Per. Med.14(2), 141–152 (2017).
- Syapse . Precision medicine goes mainstream at leading health systems (2019). https://syapse.com/company/blog/precision-medicine-goes-mainstream-at-leading-health-systems
- Kean M , PritchardD. Emerging models for clinical adoption of personalized medicine. Precis. Med.2017, 52–65 (2017).
- Lemke AA , HuttenSelkirk CG , GlaserNSet al. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Per. Med.14(5), 389–400 (2017).
- Lemke AA , ThompsonJ , HulickPJet al. Primary care physician experiences utilizing a family health history tool with electronic health record–integrated clinical decision support: an implementation process assessment. J. Community Genet.11, 339–350 (2020).
- David SP , DunnenbergerHM , AliRet al. Implementing primary care mediated population genetic screening within an integrated health system. J. Am. Board Fam. Med.34(4), 861–865 (2021).
- Lemke AA , AmendolaLM , ThompsonJet al. Patient-reported outcomes and experiences with population genetic testing offered through a primary care network. Genet. Test. Mol. Biomarkers25(2), 152–160 (2021).
- Helseth DL Jr , GulukotaK , MillerNet al. Flype: software for enabling personalized medicine. Am. J. Med. Genet. C Semin. Med. Genet.187(1), 37–47 (2021).